Aspect Biosystems Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
110
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$115M
- Investors
-
37
Aspect Biosystems General Information
Description
Developer of a full-stack tissue therapeutic platform designed to innovate at the intersection of biology, medicine, and engineering to build living human tissues. The company's platform offers proprietary microfluidic three-dimensional bioprinting technology that creates advances in understanding fundamental biology, disease research, development of novel therapeutics, and regenerative medicine, enabling researchers to understand the creation of human tissues for medical research, therapeutic discovery, and medicine products.
Contact Information
Website
www.aspectbiosystems.comCorporate Office
- 887 Great Northern Way
- Suite 500
- Vancouver, British Columbia V5T 4T5
- Canada
Corporate Office
- 887 Great Northern Way
- Suite 500
- Vancouver, British Columbia V5T 4T5
- Canada
Aspect Biosystems Timeline
Aspect Biosystems Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 15. Later Stage VC (Series B) | 08-Jan-2025 | $115M | Completed | Generating Revenue | ||
| 14. Grant | 10-Jul-2024 | Completed | Generating Revenue | |||
| 13. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 12. Later Stage VC | 12-Apr-2023 | Completed | Generating Revenue | |||
| 11. Grant | 20-Mar-2023 | Completed | Generating Revenue | |||
| 10. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 9. Later Stage VC (Series A) | 01-Jun-2020 | Completed | Generating Revenue | |||
| 8. Grant | 15-Nov-2018 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 15-Mar-2018 | $783K | $783K | Completed | Generating Revenue | |
| 6. Early Stage VC | 31-Jul-2017 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Aspect Biosystems Comparisons
Industry
Financing
Details
Aspect Biosystems Competitors (9)
One of Aspect Biosystems’s 9 competitors is REGENHU, a Venture Capital-Backed company based in Villaz-Saint-Pierre, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| REGENHU | Venture Capital-Backed | Villaz-Saint-Pierre, Switzerland | ||||
| InSphero | Venture Capital-Backed | Schlieren, Switzerland | ||||
| Synthecon | Formerly Accelerator/Incubator backed | Houston, TX | ||||
| VoxCell BioInnovation | Venture Capital-Backed | Victoria, Canada | ||||
| VivoSim Labs | Formerly VC-backed | San Diego, CA |
Aspect Biosystems Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Aspect Biosystems Patents
Aspect Biosystems Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023271390-A1 | Systems and methods for fabricating bioprinted fiber structures | Pending | 15-May-2022 | ||
| AU-2023273544-A1 | Compositions and methods for treating diabetes | Pending | 15-May-2022 | ||
| EP-4526102-A1 | Systems and methods for fabricating bioprinted fiber structures | Pending | 15-May-2022 | ||
| EP-4525894-A1 | Compositions and methods for treating diabetes | Pending | 15-May-2022 | ||
| AU-2022408220-A1 | Radial pump assembly and methods of using same | Pending | 16-Dec-2021 | B29C64/336 |
Aspect Biosystems Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Aspect Biosystems Investors (37)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Dimension (United States) | Venture Capital | Minority | ||
| InBC Investment | Venture Capital | Minority | ||
| T1D Fund | Venture Capital | Minority | ||
| British Columbia Ministry of Economic Development | Government | |||
| Novo Nordisk | Corporation |
Aspect Biosystems FAQs
-
When was Aspect Biosystems founded?
Aspect Biosystems was founded in 2013.
-
Where is Aspect Biosystems headquartered?
Aspect Biosystems is headquartered in Vancouver, Canada.
-
What is the size of Aspect Biosystems?
Aspect Biosystems has 110 total employees.
-
What industry is Aspect Biosystems in?
Aspect Biosystems’s primary industry is Biotechnology.
-
Is Aspect Biosystems a private or public company?
Aspect Biosystems is a Private company.
-
What is Aspect Biosystems’s current revenue?
The current revenue for Aspect Biosystems is .
-
How much funding has Aspect Biosystems raised over time?
Aspect Biosystems has raised $211M.
-
Who are Aspect Biosystems’s investors?
Dimension (United States), InBC Investment, T1D Fund, British Columbia Ministry of Economic Development, and Novo Nordisk are 5 of 37 investors who have invested in Aspect Biosystems.
-
Who are Aspect Biosystems’s competitors?
REGENHU, InSphero, Synthecon, VoxCell BioInnovation, and VivoSim Labs are some of the 9 competitors of Aspect Biosystems.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
